Sara Naimimohasses ^* Shaf Keshavjee ^* Bo Wang ^* Mike Brudno ^* Aman Sidhu ^* Mamatha Bhat ^*

• University Health Network (UHN), Toronto, Canada

With recent advancements in deep learning (DL) techniques, the use of artificial intelligence (AI) has increasingly become prevalent in all fields. Currently valued at 9.01 billion USD, it is a rapidly growing market, projected to increase by 40% per annum. There has been great interest in how AI could transform the practice of medicine, with the potential to improve all healthcare spheres from workflow management, accessibility and cost efficiency to enhanced diagnostics with improved prognostic accuracy, allowing the practice of precision medicine. The applicability of AI is particularly promising for Transplant medicine, where it can help navigate the complex interplay of a myriad of variables and improve patient care. However, caution must be exercised when developing DL models, ensuring they are trained with large, reliable and diverse data sets to minimize bias and enhance generalizability.There must be transparency in the methodology and extensive validation of the model, including randomized-controlled trials to demonstrate performance and cultivate trust amongst physicians and patients. Furthermore, there is a need for regulation of this rapidly evolving field, with updated policies for the governance of AI-based technologies. Taking this in consideration, we summarize the latest Transplant-AI developments from the Ajmera Transplant Center's inaugural symposium.